Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Shota Kikuno"'
Autor:
Nozomi Harai, Akihiro Nishimura, Kimio Matsumura, Yuya Suzuki, Shota Kikuno, Tetsuro Kobayashi, Kaoru Nagasawa, Yasumichi Mori
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 8, Pp 1387-1395 (2022)
ABSTRACT Aims/Introduction To investigate factors influencing glycemic control in diabetes mellitus complicated by autoimmune pancreatitis. Materials and Methods This retrospective cohort study investigated 33 patients with diabetes mellitus complica
Externí odkaz:
https://doaj.org/article/575afaa1b97a4661bec5a7ae548a2819
Publikováno v:
Clinical Case Reports, Vol 9, Iss 1, Pp 278-281 (2021)
Abstract Octreotide may be useful in noninsulinoma pancreatogenous hypoglycemia syndrome with nesidioblastosis patients who was on hemodialysis. Continuous octreotide subcutaneous infusion can reduce side‐effects and stabilize plasma glucose levels
Externí odkaz:
https://doaj.org/article/13dc7eeca1344453a85c02caa6e06c3d
Autor:
Takatoshi Kasai, Yasumichi Mori, Akihiro Nishimura, Kaoru Nagasawa, Shota Kikuno, Kimio Matsumura, Koji Narui, Minoru Okubo
Publikováno v:
J Clin Sleep Med
STUDY OBJECTIVES: Although recent studies suggest that obstructive sleep apnea during rapid eye movement (REM) is associated with different cardiometabolic and neurocognitive risks compared with non-REM (NREM) sleep, there is no information on whethe
Publikováno v:
Clinical Case Reports, Vol 9, Iss 1, Pp 278-281 (2021)
Clinical Case Reports
Clinical Case Reports
Octreotide may be useful in noninsulinoma pancreatogenous hypoglycemia syndrome with nesidioblastosis patients who was on hemodialysis. Continuous octreotide subcutaneous infusion can reduce side‐effects and stabilize plasma glucose levels.
Autor:
Yasumichi Mori, Kimio Matsumura, Kaoru Nagasawa, Minoru Okubo, Tetsuro Kobayashi, Shota Kikuno, Akihiro Nishimura
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 12:2461-2477
Slowly progressive type 1 insulin-dependent diabetes mellitus (SPIDDM), sometimes referred to as latent autoimmune diabetes in adults (LADA), is a heterogeneous disease that is often confused with type 1 and type 2 diabetes. As a result, there were f
Autor:
Yasumichi Mori, Shota Kikuno, Koji Narui, Kaoru Nagasawa, Minoru Okubo, Takatoshi Kasai, Akihiro Nishimura
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 104:2075-2082
Context Recent studies based on home sleep apnea testing (HSAT) reported the potential association of sleep disordered breathing, such as obstructive sleep apnea (OSA), with diabetic retinopathy (DR). A few studies showed that the apnea-hypopnea inde
Autor:
Takayasu Uchida, Yasumichi Mori, Shota Kikuno, Minoru Okubo, Koji Narui, Kaoru Nagasawa, Akihiro Nishimura, Takatoshi Kasai
Publikováno v:
Sleepbreathing = SchlafAtmung. 25(1)
Sleep-disordered breathing (SDB) is associated with hypertension, poor glycemic control and dyslipidemia. Usually, apnoea events tend to be more prominent during rapid eye movement (REM) sleep than non-REM (NREM) sleep. We examined which SDB paramete
Autor:
Shota Kikuno, Koji Narui, Takayasu Uchida, Yasumichi Mori, Kaoru Nagasawa, Takatoshi Kasai, Akihiro Nishimura, Minoru Okubo
Publikováno v:
Diabetes. 67
Sleep disordered breathing (SDB) is associated with hypertension, poor glycemic control and dyslipidemia. In general, apnea events are more prominent during rapid eye movement (REM) sleep than non-REM (NREM) sleep. Reportedly, only REM-AHI is associa
Autor:
Akihiro Nishimura, Yasumichi Mori, Takatoshi Kasai, Shota Kikuno, Kaoru Nagasawa, Minoru Okubo, Koji Narui
Sleep-disordered breathing (SDB) can induce hyperglycemia, hypertension, and oxidative stress, conditions that are known to cause kidney damage. Therefore, SDB may exacerbate albuminuria, which is an established marker of early-stage kidney damage in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0cb3cf1989444499aa3e62da5755deb
https://europepmc.org/articles/PMC5837841/
https://europepmc.org/articles/PMC5837841/
Publikováno v:
Rinsho Shinkeigaku. 54:643-647
We report on the case of a 77-year-old male with genetically proven spinocerebellar ataxia type 31 (SCA31) who had dystonia. He was referred to our hospital for evaluation following a 6-year history of slowly progressive unsteadiness of his left leg